BD Announces Enrollment in Post-Market Studies of the WavelinQ(TM) Arteriovenous Endovascular Fistula

FRANKLIN LAKES, N.J., April 29, 2021 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that enrollment has begun and the first patients have been treat... Devices BD , WavelinQT, EndoAVF System, dialysis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news